TDM Guided Early Optimization of ADAL in Crohn's Disease

NCT03261102 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease
Drug Monitoring
Inflammatory Bowel Diseases

Interventions

BIOLOGICAL: Adalimumab

Sponsor

waqqas.afif

Collaborators

[object Object]